Merck revenue falls as dollar strengthens
February 03, 2016 at 06:57 AM EST
Feb 3 (Reuters) - Merck & Co Inc reported a 2.5 percent fall in quarterly revenue, hurt by a strong dollar and declining sales of its Remicade arthritis treatment.